DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against Tau-Induced Destabilization

Target: DAPK1 Composite Score: 0.579 Price: $0.58 Citation Quality: Pending neurodegeneration Status: promoted

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

🔴 Alzheimer's Disease 🧠 Neurodegeneration

✓ All Quality Gates Passed

Quality Report Card click to collapse

C+

Composite: 0.579

Top 18% of 513 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

B+ Mech. Plausibility 15% 0.75 Top 38%

B Evidence Strength 15% 0.68 Top 42%

A Novelty 12% 0.82 Top 36%

C Feasibility 12% 0.42 Top 75%

B+ Impact 12% 0.72 Top 44%

D Druggability 10% 0.35 Top 82%

D Safety Profile 8% 0.38 Top 85%

A Competition 6% 0.88 Top 24%

C+ Data Availability 5% 0.58 Top 67%

B Reproducibility 5% 0.60 Top 50%

Evidence

8 supporting | 5 opposing

Citation quality: 0%

Debates

0 sessions

No debates yet

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for tauopathies given tau's destabilizing role?

The abstract challenges the rationale for using microtubule-stabilizing drugs in tau diseases, since tau appears to destabilize rather than stabilize microtubules. This paradigm shift has immediate implications for therapeutic development but requires validation. Gap type: open_question Source paper: Tau: It's Not What You Think. (2019, Trends Cell Biol, PMID:30929793)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (1)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly Targeting Tau

Score: 0.609 | Target: MAP2K7/MAP3K12

→ View full analysis & all 2 hypotheses

Description

Death-Associated Protein Kinase 1 (DAPK1) phosphorylates tau at multiple pathogenic sites (Ser214, Ser262, Ser396), promotes Aβ42-induced apoptosis, and mediates Parkin inactivation disrupting mitophagy. Hydrophobic tagging-mediated selective degradation of DAPK1 demonstrates attenuation of tau pathology in experimental models.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

13 citations 9 with PMID Validation: 0% 8 supporting / 5 opposing

Evidence Matrix — sortable by strength/year, click Abstract to expand

Claim	Type	Source	Strength ↕	Year ↕	PMIDs	Abstract
Death-associated protein kinase 1 mediates Aβ42 ag…	Supporting	-	-	-	PMID:35002518	-
DAPK1 has a critical role in aberrant tau protein …	Supporting	-	-	-	PMID:24853415	-
Inhibition of DAPK1 attenuates cis P-tau and neuro…	Supporting	-	-	-	PMID:33979671	-
Selective degradation of DAPK1 via a novel hydroph…	Supporting	-	-	-	PMID:41461311	-
miR-143-3p Inhibits Aberrant Tau Phosphorylation b…	Supporting	-	-	-	PMID:35887339	-
DAPK1 as a Therapeutic Target for Alzheimer's…	Supporting	-	-	-	PMID:38195518	-
DAPK1-dependent tau SUMOylation leads to cognitive…	Supporting	-	-	-	PMID:41272902	-
STRING interaction: DAPK1-PPP2CA score 0.457 - con…	Supporting	-	-	-	-	-
No CNS-penetrant DAPK1 inhibitor exists in any sta…	Opposing	-	-	-	-	-
DAPK1 knockout mice show abnormalities in immune f…	Opposing	-	-	-	PMID:30062675	-
DAPK1 may be downstream of Aβ - inhibition may not…	Opposing	-	-	-	PMID:35002518	-
Limited evidence for direct DAPK1-tau site specifi…	Opposing	-	-	-	-	-
Hydrophobic tagging mechanism not therapeutically …	Opposing	-	-	-	-	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 8

Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation i…▼

Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease

PMID:35002518

DAPK1 has a critical role in aberrant tau protein regulation and function

PMID:24853415

Inhibition of DAPK1 attenuates cis P-tau and neurodegeneration in traumatic brain injury

PMID:33979671

Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer's disease

PMID:41461311

miR-143-3p Inhibits Aberrant Tau Phosphorylation by Directly Targeting DAPK1

PMID:35887339

DAPK1 as a Therapeutic Target for Alzheimer's Disease - comprehensive review

PMID:38195518

DAPK1-dependent tau SUMOylation leads to cognitive dysfunction in tauopathy mouse models

PMID:41272902

STRING interaction: DAPK1-PPP2CA score 0.457 - connects to phosphatase regulatory network

✗ Opposing Evidence 5

No CNS-penetrant DAPK1 inhibitor exists in any stage of clinical development

DAPK1 knockout mice show abnormalities in immune function and tumor susceptibility

PMID:30062675

DAPK1 may be downstream of Aβ - inhibition may not address disease initiation

PMID:35002518

Limited evidence for direct DAPK1-tau site specificity vs. GSK3β/CDK5 contributions

Hydrophobic tagging mechanism not therapeutically scalable for chronic CNS dosing

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.